Search Results - "Pu, Tianjie"
-
1
MAOA promotes prostate cancer cell perineural invasion through SEMA3C/PlexinA2/NRP1–cMET signaling
Published in Oncogene (18-02-2021)“…Perineural invasion (PNI), a pathologic feature defined as cancer cell invasion in, around, and through nerves, is an indicator of poor prognosis and survival…”
Get full text
Journal Article -
2
MAOA-mediated reprogramming of stromal fibroblasts promotes prostate tumorigenesis and cancer stemness
Published in Oncogene (16-04-2020)“…The tumor microenvironment plays a critical role in prostate cancer (PC) development and progression. Inappropriate activation of the stroma potentiates the…”
Get full text
Journal Article -
3
Prognostic Score-Based Stratification Analysis Reveals Universal Benefits of Radiotherapy on Lowering the Risk of Ipsilateral Breast Event for Ductal Carcinoma In Situ Patients with Different Risk Levels
Published in Annals of surgical oncology (01-02-2021)“…Background We aimed to analyze the effects of radiotherapy (RT) on the incidence rate of ipsilateral breast event (IBE) in ductal carcinoma in situ (DCIS)…”
Get full text
Journal Article -
4
Repression of miR-135b-5p promotes metastasis of early-stage breast cancer by regulating downstream target SDCBP
Published in Laboratory investigation (01-09-2019)“…Metastasis is an essential event for breast cancer (BC) progression even after initial surgery. The identification of patients with a high probability of…”
Get full text
Journal Article -
5
The differences of clinicopathologic characteristics among subgroups of reclassified HER2 fluorescence in situ hybridization (FISH) according to the ASCO/CAP 2018 breast cancer HER2 testing guidelines
Published in Journal of clinical pathology (01-05-2020)“…The aim of this study is to analyse differences in clinicopathologic features among reclassified human epidermal growth factor receptor-2 (HER2) fluorescence…”
Get more information
Journal Article -
6
High expression of microRNA20b is associated with malignant clinicopathological features and poor prognosis in breast phyllodes tumor
Published in International journal of clinical oncology (01-12-2020)“…Background microRNAs, which expound the transcriptional regulation of gene expression, have been validated as prognostic markers in many tumors. The…”
Get full text
Journal Article -
7
Clinical significance and prognostic value of receptor conversion in hormone receptor positive breast cancers after neoadjuvant chemotherapy
Published in World journal of surgical oncology (07-03-2018)“…Neoadjuvant chemotherapy (NAC) is widely used in advanced breast cancer patients. However, there is little known about conversion frequency of estrogen…”
Get full text
Journal Article -
8
WLS-Wnt signaling promotes neuroendocrine prostate cancer
Published in iScience (22-01-2021)“…Neuroendocrine prostate cancer (NEPC) is a lethal prostate cancer subtype arising as a consequence of more potent androgen receptor (AR) targeting in…”
Get full text
Journal Article -
9
External quality assessment (EQA) program for the immunohistochemical detection of ER, PR and Ki-67 in breast cancer: results of an interlaboratory reproducibility ring study in China
Published in BMC cancer (22-10-2019)“…An External Quality Assessment (EQA) program was developed to investigate the status of estrogen receptor (ER), progesterone receptor (PR), and Ki-67…”
Get full text
Journal Article -
10
Screening of Recurrence Related MicroRNA in Ductal Carcinoma In Situ and Functional Study of MicroRNA-654-5p
Published in Journal of breast cancer (01-03-2019)“…Ductal carcinoma (DCIS) contributes to 20%-30% of newly diagnosed cases of breast cancer in China. Although the breast cancer-specific mortality of DCIS is…”
Get full text
Journal Article -
11
The expression of aldehyde dehydrogenase family in breast cancer
Published in Journal of breast cancer (01-03-2014)“…It is widely accepted that aldehyde dehydrogenase (ALDH) activity is a signature of breast cancer stem cells, and high activity has been reported to be…”
Get full text
Journal Article -
12
Inhibition of CHRM1 reverts docetaxel resistance in castration‐resistant prostate cancer
Published in The FASEB journal (01-05-2022)“…Background Chemotherapy remains the major treatment option for castration‐resistant prostate cancer (CRPC). Docetaxel (DTX)‐based chemotherapy provides…”
Get full text
Journal Article -
13
Neuropilin-2 promotes lineage plasticity and progression to neuroendocrine prostate cancer
Published in Oncogene (09-09-2022)“…Neuroendocrine prostate cancer (NEPC), a lethal subset of prostate cancer, is characterized by loss of AR signaling and resulting resistance to AR-targeted…”
Get full text
Journal Article -
14
Biomarker profile of invasive lobular carcinoma: pleomorphic versus classic subtypes, clinicopathological characteristics and prognosis analyses
Published in Breast cancer research and treatment (01-07-2022)“…Purpose To compare the clinicopathologic features and prognosis of pleomorphic invasive lobular carcinoma (P-ILC) and classic ILC (C-ILC) according to the…”
Get full text
Journal Article -
15
Bidirectional Cross-talk between MAOA and AR Promotes Hormone-Dependent and Castration-Resistant Prostate Cancer
Published in Cancer research (Chicago, Ill.) (15-08-2021)“…Androgen receptor (AR) is the primary oncogenic driver of prostate cancer, including aggressive castration-resistant prostate cancer (CRPC). The molecular…”
Get full text
Journal Article -
16
Genomic landscape of secretory carcinoma of the breast with axillary lymph node metastasis
Published in Pathology, research and practice (01-03-2022)“…Secretory carcinoma of the breast (SCB) is a rare low-grade often triple-negative breast carcinoma. We aim to analyze the pathological and molecular features…”
Get full text
Journal Article -
17
Clinicopathologic characteristics of HER2-positive metaplastic squamous cell carcinoma of the breast
Published in Journal of clinical pathology (01-01-2022)“…The aim of this study was to analyse the clinicopathological features and prognosis of human epidermal growth factor receptor-2 (HER2)-positive metaplastic…”
Get more information
Journal Article -
18
Downregulation of miR-221-3p and upregulation of its target gene PARP1 are prognostic biomarkers for triple negative breast cancer patients and associated with poor prognosis
Published in Oncotarget (12-12-2017)“…The purpose of this study was to identify microRNAs (miRNAs) closely associated with the prognosis of triple-negative breast cancer (TNBC) and their possible…”
Get full text
Journal Article -
19
Bidirectional Crosstalk between MAOA and AR Promotes Hormone-Dependent and Castration-Resistant Prostate Cancer
Published in Cancer research (Chicago, Ill.) (24-06-2021)“…Androgen receptor (AR) is the primary oncogenic driver of prostate cancer (PC), including aggressive castration-resistant prostate cancer (CRPC). The molecular…”
Get full text
Journal Article -
20
FGFR1 and HER1 or HER2 co-amplification in breast cancer indicate poor prognosis
Published in Oncology letters (01-06-2018)“…Human epidermal growth factor receptor 1 or 2 (HER1/2), and fibroblast growth factor receptor 1 (FGFR1) signaling serve critical roles in the progression of…”
Get full text
Journal Article